Sutaria Saumya, Chairman & CEO of Tenet Healthcare (THC), has demonstrated a consistent pattern of selling activity over 34 reported transactions, with no recorded purchases. SEC Form 4 filings reveal total sales exceeding $93.8 million, all concentrated in THC shares. Recent activity includes three notable dispositions on February 27, 2026, totaling $39.2 million—comprising a $29.9 million sale alongside transactions of $7.2 million and $2.2 million. This follows earlier sales in late 2025, including a $13.1 million transaction on December 31 and two September 10 sales worth $11.3 million and $3.7 million.
The transactions primarily involve derivative dispositions (coded "F") and open-market sales (coded "S"), with no offsetting acquisitions. While some filings show zero-dollar transactions (coded "A" and "M"), these likely represent awards or option exercises without immediate monetization. The absence of buying activity and the scale of dispositions—particularly the multi-million-dollar sales clustered in late February 2026—suggest a sustained reduction in Saumya's THC holdings. The pattern aligns with a broader trend of executive divestment rather than accumulation, though the filings do not indicate whether the sales were prearranged or discretionary.
AI-assisted summary